Phase I trial finds breast cancer vaccine triggers an immune response and is safe

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Continue Reading

News Source: medicalxpress.com